17
Participants
Start Date
October 31, 2015
Primary Completion Date
February 28, 2018
Study Completion Date
April 30, 2018
3BNC117
3BNC117 infusions
Antiretroviral Treatment Interruption
Antiretroviral therapy will be discontinued 2 days after the third 3BNC117 infusion, at week 24, and resumed at week 36.
The Rockefeller University, New York
Weill Cornel Medical Center, New York
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Bill and Melinda Gates Foundation
OTHER
Weill Medical College of Cornell University
OTHER
Montefiore Medical Center
OTHER
Rockefeller University
OTHER